AKT1 and hepatocellular carcinoma: PKI-587 inhibited proliferation, promoted apoptosis, and enhanced radiosensitization of hepatocellular carcinoma cells by blocking abnormal, radiation-induced activation of the PI3K/AKT/mTOR and DNA damage repair pathways and their downstream effector molecules.